Listing & Compliance Notices

Roth CH Acquisition Co. received a nasdaq deficiency notice notice regarding other (rules 5620(a)).

“January 11, 2024, Roth CH Acquisition Co. (the “Company”) received a deficiency notice (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that it is not in compliance with Nasdaq Listing Rule 5620(a), which requires that Nasdaq-listed companies hold an annual meeting of shareholders within twelve months of their fiscal year end (the “Annual Meeting Requirement”), because the Company did not hold an annual meeting of shareholders within twelve months of its fiscal year ended December 31, 2022. The notification”

TuSimple Holdings Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“July 22, 2024, to regain compliance with the Bid Price Requirement. As disclosed in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on January 17, 2024, the Company notified Nasdaq on January 16, 2024 of the Company’s intention to voluntarily delist its Common Stock from Nasdaq and to terminate the registration of the Common Stock with the SEC. On January 29, 2024, the Company filed a Form 25 Notification of Removal from Listing and/or Registration Under Section 12(b) of the Securities Exchange Act of 1934 with the SEC. SIGNATURES Pursuant”

Fresh2 Group Ltd received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“January 26, 2024, Fresh2 Group Limited (the “Company”) received a deficiency notice (the “Notice”) from The Nasdaq Stock Market (“Nasdaq”) informing the Company that it failed to comply with the $1 minimum bid price required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) based upon the closing bid price of the American Depositary Shares (“ADSs”) of the Company for the 30 consecutive business days prior to the date of the Notice from Nasdaq. Nasdaq’s Notice has no immediate effect on the listing of the Company’s ADSs on The Nasdaq Capital Market. Pursuan”

Danimer Scientific, Inc. received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

“January 23, 2024, Danimer Scientific, Inc. (the “Company”) was notified by NYSE Regulation (“NYSER”) that the Company is not in compliance with the New York Stock Exchange’s (“NYSE”) continued listing criteria under Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company’s common stock was less than $1.00 over a consecutive 30 trading-day period as of January 22, 2024. The Company has notified the NYSE of its intent to cure the deficiency and return to compliance with the NYSE continued listing requirements. The Company will return to compliance if, d”

Enviva Inc. received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

“January 23, 2024, Enviva Inc. (the “ Company ”) was notified by the New York Stock Exchange (the “ NYSE ”) that the average closing price of the Company’s shares of common stock, par value $0.001 per share (the “ Common Stock ”), had fallen below $1.00 per share over a period of 30 consecutive trading days, which is the minimum average closing price required to maintain continued listing on the NYSE under Section 802.01C of the NYSE Listed Company Manual. Under the NYSE’s rules, the Company has a period of six months following receipt of the notice to regain compliance with the minimum share p”

SPLASH BEVERAGE GROUP, INC. received a nyse_american deficiency notice notice regarding stockholders equity (rules 1003(a)(ii)).

“December 20, 2023, the Company received a notification (the “Plan Letter”), with NYSE acceptance of the proposed plan and further deficiency notice. In the Plan Letter the NYSE indicated that in addition to Section 1003(a)(i) of the Company Guide, the Company was also not in compliance with Section 1003(a)(ii) of the Company Guide, requiring a listed company to have stockholders’ equity of at least $4.0 million if it has reported losses from continuing operations or net losses in three of its four most recent fiscal years. If the Company is not in compliance with the continued listing standard”

SPLASH BEVERAGE GROUP, INC. received a nyse_american deficiency notice notice regarding stockholders equity (rules 1003(a)(i)).

“October 6, 2023, the Splash Beverage Group, Inc. (the “Company”) received a notification (the “Deficiency Letter”) from the staff at NYSE American LLC (“NYSE American”) that it was not in compliance with Section 1003(a)(i) of the continued listing standards set forth in the NYSE American Company Guide (the “Company Guide”), requiring a listed company to have stockholders’ equity of (i) at least $2.0 million if it has reported losses from continuing operations or net losses in two of its three most recent fiscal years. The Company submitted a proposed compliance plan to the NYSE American. Advis”

BROADWAY FINANCIAL CORP \DE\ received a nasdaq extension granted notice regarding late filing (rules 5250(c)(1)).

“January 26, 2024, Broadway Financial Corporation (the “Company”) received an extension from The Nasdaq Stock Market LLC (“Nasdaq”) to May 13, 2024 (the “Extension Deadline”) for the Company to file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 (the “Form 10-Q”) with the U.S. Securities and Exchange Commission, to regain compliance with Rule 5250(c)(1). The Company anticipates filing the Form 10-Q on or before the Extension Deadline. As previously reported, there is no immediate impact on the Company’s listing status on The Nasdaq Capital Market at this time. *”

AMARIN CORP PLCUK received a nasdaq compliance regained notice regarding minimum bid price (rules 5450(a)(1)).

“January 25, 2024, Amarin Corporation plc (the “Company”) received a letter from The NASDAQ Stock Market LLC (“Nasdaq”) informing the Company that it has regained compliance with the minimum bid price requirement under NASDAQ Listing Rule 5450(a)(1) for continued listing on The NASDAQ Global Market. Consequently, the Company is now in compliance with all applicable listing standards, and it will continue to be listed on The NASDAQ Global Market. The Company was previously notified by Nasdaq on October 30, 2023 that it was not in compliance with the minimum bid price requirement because its Amer”

VERU INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“January 25, 2024, Veru Inc. (the “Company”) received notification from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the requirement to maintain a minimum closing bid price of $1.00 per share, as set forth in Nasdaq Listing Rule 5550(a)(2), because the closing bid price of the Company’s common stock (the “Common Stock”) was below $1.00 per share for 30 consecutive business days. The notification does not impact the listing of the Company’s Common Stock on the Nasdaq Capital Market at this time. In accordance with Nasdaq Listing Rule 5810(c)(3)(A”

Finnovate Acquisition Corp. received a nasdaq deficiency notice notice regarding other (rules 5620(a)).

“January 22, 2024, Finnovate Acquisition Corp. (the “Company”) received a deficiency notice (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that it is not in compliance with Nasdaq Listing Rule 5620(a), which requires that Nasdaq-listed companies hold an annual meeting of shareholders within twelve months of their fiscal year end (the “Annual Meeting Requirement”), because the Company did not hold an annual meeting of shareholders within twelve months of its fiscal year ended December 31, 2022. The notifica”

Landcadia Holdings IV, Inc. received a nasdaq deficiency notice notice regarding other (rules 5620(a)).

“January 24, 2024, Landcadia Holdings IV, Inc. (“we” or “our”) received a letter from The Nasdaq Stock Market (“Nasdaq”) stating that we were not in compliance with the Nasdaq Listing Rule 5620(a) (the “Rule”) requiring that we hold an annual meeting of stockholders within 12 months of the end of our fiscal year. In accordance with Nasdaq Listing Rule 5810(c)(2)(G), we have 45 calendar days (or until March 11, 2024) to submit a plan to regain compliance and, if Nasdaq accepts the plan, Nasdaq may grant us up to 180 calendar days from our fiscal year end, or until June 28, 2024, to regain compli”

Nauticus Robotics, Inc. received a nasdaq noncompliance notice notice regarding minimum bid price.

“January 22, 2024, Nauticus Robotics, Inc. (the “Company”) received written notice from Nasdaq notifying it that the average closing bid price of the Company’s shares of common stock was below the minimum closing bid price of $1 per share during the last 30 consecutive trading days, as required for continued listing on the Nasdaq under Nasdaq’s listing rules (the “Rules”). The notice has no immediate impact on the listing of the Company’s common stock and warrants, which will continue to be listed and trade on Nasdaq subject to the Company’s continued compliance with the other listing requireme”

BurgerFi International, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“January 23, 2024, BurgerFi International, Inc. (the “Company”) received a notice (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rules 5450(a)(1) (the “Bid Price Rule”) for continued listing. The Bid Price Rule requires listed securities to maintain a minimum bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) (the “Compliance Period Rule”) provides that a failure to meet the minimum bid price req”

Phio Pharmaceuticals Corp. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“January 24, 2024, Phio Pharmaceuticals Corp. (the “Company”) received written notice (the “Notification Letter”) from The Nasdaq Capital Market (“Nasdaq”) stating that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”) because the Company’s common stock failed to maintain a minimum closing bid price of $1.00 for 30 consecutive business days. The Notice has no immediate effect on the Nasdaq listing or trading of the Company’s common stock The Notification Letter provides an initial 180 calendar day period, or until July 22, 2024, in which to reg”

CIMG Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“January 23, 2024, NuZee, Inc. (the “Company”) received a notice (the “Notice”) from the Listing Qualifications staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that the Company’s stockholders’ equity as reported in its Annual Report on Form 10-K for the period ended September 30, 2023 (“Form 10-K”), did not satisfy the continued listing requirement under Nasdaq Listing Rule 5550(b)(1) for the Nasdaq Capital Market, which requires that a listed company’s stockholders’ equity be at least $2,500,000. In its Form 10-K, the Company reported stockholders’ equity of $1,674,357, and”

RiskOn International, Inc. received a nasdaq deficiency notice notice regarding board independence (rules 5605, 5605(b)(1)(A)).

“January 23, 2024, RiskOn International, Inc., a Nevada corporation (the “ Company ”), received a written notice (the “ Notice ”) from The Nasdaq Stock Market LLC (“ Nasdaq ”), indicating that, as a result of Milton C. Ault, III’s appointment to the board of directors of the Company (the “ Board ”) effective January 4, 2024, the Company currently has six (6) directors, with only three (3) of which qualify as independent directors. As such, the Company no longer complies with Nasdaq’s independent director requirement as set forth in Listing Rule 5605, which requires, among other things, a listed”

COMSovereign Holding Corp. received a nasdaq noncompliance notice notice regarding stockholders equity (rules 5550(b)(1)).

“January 24, 2024, COMSovereign Holding Corp. (the “Company”) received written notice from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it was not in compliance with Nasdaq Listing Rule 5550(a)(2), because the closing bid price for the Company’s common shares was below $1.00 per share for the last 30 consecutive business days. Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has been granted a 180-calendar day compliance period, or until July 22, 2024, to regain compliance with the minimum bid price requirement. To”

COMSovereign Holding Corp. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“January 24, 2024, COMSovereign Holding Corp. (the “Company”) received written notice from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it was not in compliance with Nasdaq Listing Rule 5550(a)(2), because the closing bid price for the Company’s common shares was below $1.00 per share for the last 30 consecutive business days. Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has been granted a 180-calendar day compliance period, or until July 22, 2024, to regain compliance with the minimum bid price requirement. To”

Adamas One Corp. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) indicating that, since the Company has not yet filed its Annual Report on Form 10-K for the period ended September 30, 2023 (the “ Form 10-K ”), it no longer complies with Nasdaq Listing Rule 5250(c)(1) for continued listing. As a result of this delinquency of not timely filing the Form 10-K, the Company now has 60 calendar days, until March 19, 2024, to submit a plan to regain compliance and if Nasdaq accepts such plan, Nasdaq may grant an exception of up to 180 calendar days from the o”

Perception Capital Corp. IV received a nyse deficiency notice notice regarding shareholders (rules 802.01B).

“January 19, 2024, RCF Acquisition Corp. (the “Company”) received a notice from the New York Stock Exchange (the “NYSE”) that it was not in compliance with the NYSE’s continued listing requirements. Specifically, the NYSE advised the Company that it is not in compliance with Section 802.01B of the NYSE Listed Company Manual, which requires an NYSE-listed company to maintain a minimum of 300 public stockholders on a continuous basis. The Company will, within 45 days from the receipt of the notice, submit a business plan to the NYSE demonstrating the Company’s ability to regain compliance with th”

Berenson Acquisition Corp. I received a nyse_american deficiency notice notice regarding shareholders (rules 1003(b)(i)(B), 1009).

“January 19, 2024, Berenson Acquisition Corp. I (the “Company”) received a written notice (the “Notice”) from the staff of NYSE Regulation of the New York Stock Exchange (“NYSE Regulation”) indicating that the Company is not currently in compliance with Section 1003(b)(i)(B) of the NYSE American LLC Company Guide (the “Company Guide”), which requires the Company to maintain a minimum of 300 public stockholders on a continuous basis. In accordance with Section 1009 of the Company Guide, the Company has been provided with a period of 30 days to respond with a plan advising of actions it has taken”

Currenc Group Inc. received a nyse noncompliance notice notice regarding shareholders (rules 802.01B).

“January 19, 2024, INFINT Acquisition Corporation (the “Company”) received a notification (the “Notice”) from the New York Stock Exchange (the “NYSE”) informing the Company that, because the number of public shareholders is less than 300, the Company is not in compliance with Section 802.01B of the NYSE Listed Company Manual (the “Listing Rule”). The Listing Rule requires the Company to maintain a minimum of 300 public stockholders on a continuous basis. The Notice specifies that the Company has 45 days to submit a business plan that demonstrates how the Company expects to return to compliance”

GCT Semiconductor Holding, Inc. received a nyse noncompliance notice notice regarding shareholders (rules 802.01B).

“January 19, 2024, Concord Acquisition Corp III (the “Company”) received a notification (the “Notice”) from the New York Stock Exchange (the “NYSE”) informing the Company that, because the number of public stockholders is less than 300, the Company is not in compliance with Section 802.01B of the NYSE Listed Company Manual (the “Listing Rule”). The Listing Rule requires the Company to maintain a minimum of 300 public stockholders on a continuous basis. The Notice specifies that the Company has 45 days to submit a business plan that demonstrates how the Company expects to return to compliance wi”

FOXO TECHNOLOGIES INC. received a nyse_american deficiency notice notice regarding audit committee.

“January 19, 2024, FOXO Technologies Inc., a Delaware corporation(the “ Company ”), received an official notice of noncompliance (the “ NYSE American Notice ”) from NYSE Regulation (“ NYSE ”) stating that the Company is noncompliant with Sections 803B(2)(c) and 803B(2)(a)(iii) of the Company Guide since its audit committee is not comprised of two independent members and does not have at least one member of the audit committee who is financially sophisticated. According to Section 803(B)(6)(b) of the Company Guide, the Company will have until the earlier of its next annual meeting or one year fr”

WhiteHorse Finance, Inc. received a nasdaq noncompliance notice notice regarding board independence (rules 5605).

“January 24, 2024, the Company received a notice (the “Notice”) from the Listing Qualifications Department of Nasdaq notifying the Company that, as a result of the death of Mr. Burke, the Company no longer complies with Nasdaq’s independent director requirement as set forth in Listing Rule 5605, which requires Nasdaq-listed companies to have a board of directors comprised of a majority of independent directors. ​ Consistent with Listing Rule 5605(b)(1)(A), the Notice provides that Nasdaq will provide the Company a cure period in order to regain compliance as follows (the “Cure Period”): until t”

Panbela Therapeutics, Inc. received a nasdaq delisting notice notice regarding other (rules 5550(a)(4)).

“January 22, 2024, Panbela Therapeutics, Inc. (the “Company”) received a notice from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as of effective date of the previously reported 1-for-20 reverse stock split on January 18, 2024, the Company was no longer in compliance with Nasdaq Listing Rule 5550(a)(4) (the “Minimum Float Requirement”), which requires a minimum of 500,000 publicly held shares. The Staff informed the Company that this matter serves as an additional basis for delisting the Company’s common stock and that the Nasda”

Pegasus Digital Mobility Acquisition Corp. received a nyse deficiency notice notice regarding shareholders (rules 802.01B).

“January 19, 2024, the Company received written notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that the Company is not in compliance with the continued listing standards set forth in Section 802.01B of the NYSE Listed Company Manual because the Company has fewer than 300 public stockholders. In accordance with applicable NYSE procedures, the Company intends to deliver a business plan to the NYSE within 45 days of receipt of the Notice outlining how it intends to cure the deficiency and comply with the NYSE continued listing requirement. The Company can avoid delisting if, w”

Global System Dynamics, Inc. received a nasdaq delisting notice notice regarding other.

“January 23, 2024, we received a written notice (the “Notice Letter”) from the Nasdaq Hearings Panel (“Panel”) i ndicating that the Panel had decided to delist our securities from the Nasdaq Stock Market LLC (“Nasdaq”), starting on the opening of the business day on January 24, 2024, due to our failure to comply with the terms of the Panel’s January 2, 2024 decision (the “Decision”) for Docket No. NQ 6692C-23, our legal matter regarding delisting from the Nasdaq . Pursuant to the terms of the Decision, amongst other things, we were required to submit responses to the SEC’s comment letter dated”

Stardust Power Inc. received a nasdaq delisting notice notice regarding other (rules IM-5101-2).

“January 17, 2024, Global Partner Acquisition Corp II (the “Company” and “GPAC II”) received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, unless the Company timely requests a hearing before the Nasdaq Hearings Panel (the “Panel”), the Company’s securities (shares, warrants, and rights) would be subject to suspension and delisting from The Nasdaq Capital Market at the opening of business on January 25, 2024, due to the Company’s non-compliance with Nasdaq IM-5101-2, which requires that a special purpose acquisition company”

Social Leverage Acquisition Corp I received a nasdaq compliance regained notice regarding market value (rules 5450(b)(2)(A)).

“January 24, 2024, the Company received a letter from the Staff notifying the Company that it has regained compliance with the MVLS Rule, and the Company is therefore in compliance with Nasdaq Global’s continued listing requirements. As a result, the Staff has cancelled the hearing that was requested by the Company to appeal the Staff’s prior delisting determination and has confirmed that the Company’s Securities will continue to be listed and traded on Nasdaq Global. 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to b”

VISION SENSING ACQUISITION CORP. received a nasdaq delisting notice notice regarding market value (rules 5450(b)(2)(A), 5250(c)(1), 5450(a)(2)).

“January 17, 2024, Vision Sensing Acquisition Corp. (the “Company”) received a staff determination letter (the “Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company of the determination from the Nasdaq Staff (the “Staff”) to delist the Company’s securities from The Nasdaq Stock Market, because, as of December 26, 2023, the Company had not regained compliance with the market value requirement as set forth Listing Rule 5450(b)(2)(A) that requires the market value of the Company’s listed securities to be $50,000,000 or more. The Letter”

NRX Pharmaceuticals, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5550(a)(2)).

“October 17, 2023, NRx Pharmaceuticals, Inc. (the “Company”) received formal notice from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based upon the Company’s non-compliance with the minimum bid price requirement for continued listing on The Nasdaq Global Market, as set forth in Nasdaq Listing Rule 5450(a)(1) (the “Rule”), the Company’s securities were subject to delisting unless the Company timely requested a hearing before the Nasdaq Hearings Panel (the “Panel”). The Company timely requested a hearing before the Panel, which hearing”

Hyzon Motors Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“January 23, 2024, Hyzon Motors Inc. (the “Company”) received a letter (the “Notice”) from the listing qualifications staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rules 5550(a)(2) (the “Bid Price Rule”) for continued listing. The Bid Price Rule requires listed securities to maintain a minimum bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) (the “Compliance Period Rule”) provides that a failure to meet the minimum bid price requirement exists”

WINDTREE THERAPEUTICS INC /DE/ received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“January 22, 2024, Windtree Therapeutics, Inc. (the “Company”) received a deficiency letter from the Nasdaq Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 31 consecutive business days, the closing bid price for the Company’s common stock, par value $0.001 per share (the “Common Stock”) has been below the minimum $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (“Rule 5550(a)(2)”). The Nasdaq deficiency letter has no immediate effect on the lis”

AERWINS Technologies Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5450(a)(1)).

“below (the “Panel Decision”). As previously disclosed in the Current Report on Form 8-K filed on April 21, 2023 by the Company, on April 20, 2023, Nasdaq Listing Qualifications staff (“Staff”) notified the Company that it no longer complied with the minimum bid price requirement under Listing Rule 5450(a)(1). In accordance with Listing Rule 5810(c)(3)(A), the Company was provided 180 calendar days, or until October 17, 2023, to regain compliance with Rule 5450(a)(1) (the “Bid Price Rule”). As previously disclosed on a Form 8-K filed with the SEC on October 23, 2023, on October 18, 2023, Staff”

Kaival Brands Innovations Group, Inc. received a nasdaq extension granted notice regarding shareholders (rules 5620(a)).

“January 18, 2024 Nasdaq provided written notice to the Company that it determined to grant the Company an extension until April 29, 2024 to regain compliance with the Annual Meeting Listing Rule by holding an annual meeting of shareholders. At the annual meeting, shareholders must be afforded the opportunity to discuss Company affairs with management and, if required by the Company's governing documents, to elect directors. The Company expects to hold an annual meeting within such timeframe. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly”

Agape ATP Corp received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“January 18, 2024, Agape ATP Corporation (the “Company”) received a letter from the Listing Qualifications staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that based on the closing bid price of the Company for the period from November 30, 2023 to January 17, 2024, the Company no longer meets the continued listing requirement of Nasdaq under Nasdaq Listing Rules 5550(a)(2), to maintain a minimum bid price of $1 per share. Nasdaq has provided the Company with an 180 calendar days compliance period, or until July 16, 2024, in which to regain compliance with Nasdaq continued listi”

CEMTREX INC received a nasdaq delisting notice notice regarding other.

“January 18, 2024, the Company received a letter from The Nasdaq Stock Market LLC’s Hearings Panel notifying the Company that it has determined to delist Cemtrex Inc.’s (the “Company”) shares of Series 1 Preferred Stock from the Exchange, due to the Company’s inability to meet the terms of the exception granted by the Panel on September 8, 2023, as amended. Suspension of trading in the Company’s Series 1 Preferred Stock will be effective at the open of business on January 22, 2024.”

NextPlay Technologies Inc. received a nasdaq delisting notice notice regarding late filing (rules 5250(c)(1)).

“28 th , 2023, respectively, the Company received notification letters (the “Nasdaq Notices”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) advising the Company that it was not in compliance with Nasdaq’s continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the “Rule”) as a result of its failure to timely file its Annual Report on Form 10-K for the fiscal year ended February 28, 2023 (the “Form 10-K”) and its Quarterly Report on Form 10-Q for its fiscal quarter ended May 31, 2023 and August 31 st , 2023, respectively (the “First Form 10-Q””

REMARK HOLDINGS, INC. received a nasdaq deficiency notice notice regarding other (rules 5620(a)).

“January 16, 2024, Remark Holdings, Inc. (“we” or “our”) received a letter from The Nasdaq Stock Market (“Nasdaq”) stating that we were not in compliance with the Nasdaq Listing Rule 5620(a) (the “Rule”) requiring that we hold an annual meeting of stockholders within 12 months of the end of our fiscal year. The notification received has no immediate effect on our continued listing on the Nasdaq Capital Market, subject to our compliance with the other continued listing requirements. In the letter dated January 16, 2024, Nasdaq notified us that because we had already received a delisting notifica”

Ernexa Therapeutics Inc. received a nasdaq deficiency notice notice regarding board independence (rules 5605).

“January 17, 2024, Eterna Therapeutics Inc. (the “Company”) received a notice (the “Notice”) from the Listing Qualifications Staff (“Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) stating that, due to the appointment of Dorothy Clarke as the Company’s General Counsel, Ms. Clarke’s subsequent resignation from the committees of the Company’s Board of Directors (the “Board”) and the appointment of Sanjeev Luther as a member of the Board, the Company no longer complies with Nasdaq’s majority independent board and independent audit committee requirements as set forth in Nasdaq Listing Rule 5605”

CalAmp Corp. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5450(b)(1)(A), 5450(b)(2), 5450(b)(3)).

“January 18, 2024, CalAmp Corp. (the “Company”) received a deficiency letter (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum stockholders’ equity requirement for continued listing set forth in Nasdaq Listing Rule 5450(b)(1)(A). Nasdaq Listing Rule 5450(b)(1)(A) requires listed companies to maintain stockholders’ equity of at least $10,000,000 (the “Stockholders’ Equity Requirement”). Nasdaq further indicated that, as of the date of the Notice, the Company did not comply with certain requirements under the alternative”

Vaxart, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“en notice to Nasdaq of its intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary. The Notice did not result in the immediate delisting of the Company’s common stock from The Nasdaq Capital Market. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company originally had 180 calendar days, or until January 17, 2024, to regain compliance by maintaining a minimum closing bid price of at least $1.00 per share for a minimum of 10 consecutive trading days. Pursuant to the Extension Letter, the Company now has until July 15, 2024”

Ocean Biomedical, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5810(c)(3)(C)).

“January 17, 2024, Ocean Biomedical, Inc. (the “ Company ”) was notified (the “ Notification Letter ”) by The Nasdaq Stock Market, LLC (“ Nasdaq ”) that for the last thirty (30) consecutive business days, the Company’s Market Value of Listed Securities (“ MVLS ”) has been below the minimum requirement of $35 million for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(2). The Notification Letter has no immediate effect on the listing or trading of the Company’s common stock and the common stock will continue to trade on the Nasdaq Capital Market under the symbol”

Singular Genomics Systems, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5450(a)(1)).

“al Select Market, and listed companies must meet certain financial requirements and comply with Nasdaq’s corporate governance requirements. As previously disclosed, on July 17, 2023, the Company received a letter from Nasdaq indicating that the Company was not in compliance with Nasdaq Listing Rule 5450(a)(1) because the closing bid price per share for the Company’s common stock had closed below $1.00 for the previous 30 consecutive business days (the “Minimum Bid Price Requirement”). In response, the Company filed an application to transfer the listing of its common stock from the Nasdaq Glob”

Xilio Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“January 19, 2024, Xilio Therapeutics, Inc. (the “Company”) received a deficiency letter (the “Notice”) from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the bid price for the Company’s common stock had closed below $1.00 per share, which is the minimum bid price required to maintain continued listing on the Nasdaq Global Select Market under Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Requirement”). ​ The Notice has no immediate effect on the listing of the Company’s com”

OCA Acquisition Corp. received a nasdaq noncompliance notice notice regarding other (rules IM-5101-2).

“January 25, 2024, due to OCA’s non-compliance with Nasdaq IM-5101-2, which requires that a special purpose acquisition company complete one or more business combinations within 36 months of the effectiveness of its IPO registration statement. OCA has timely requested a hearing before the Panel to request sufficient time to complete OCA’s previously disclosed proposed business combination (the “ Business Combination ”) with Powermers Smart Industries, Inc. (“ PSI ”). The hearing request will result in a stay of any suspension or delisting action pending the hearing. There can be no assurance th”

Sharps Technology Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).

“led on Form 8-K on July 16, 2023, Sharps Technology, Inc. (the “Company”) had received a notice (the “Notice”) from the staff of the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it was not in compliance with Nasdaq Listing Rule 5550(a)(2) (the “Rule”) because it failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days dated May 26, 2023 to July 11, 2023. The Rules provide the Company a compliance period of 180 calendar days in which to regain compliance. If at any time during this 180”

Nikola Corp received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“January 19, 2024, Nikola Corporation (the “Company”) received written notice (the “Notification Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum bid price requirements set forth in Nasdaq Listing Rule 5450(a)(1) for continued listing on Nasdaq. Nasdaq Listing Rule 5450(a)(1) requires listed securities maintain a minimum closing bid price of $1.00 per share, and Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum closing bid price requirement exists if the deficiency continues for a period of 30 consecuti”